Tom Handel

Tom Handel has extensive work experience in the pharmaceutical and medical technologies industry. Tom began their career at Chevron Chemical as a Chemical Quality Assurance Analyst in 1987. Tom later worked at Invitron Corporation as a Microbiology Quality Assurance Analyst from 1988 to 1990, and then joined Syntex Laboratories as a Quality Assurance Sub-contract Coordinator in 1990.

In 1991, Handel joined Meridian Medical Technologies, where they held various roles including Manager of Quality Compliance, Senior Manager of Sterile Product Manufacturing, Senior Manager of Project Management and Technical Marketing, and Executive Director of Business Development. Tom left Meridian Medical Technologies in 1998 to work as a Senior Director of Business Development at Akorn, Inc.

Handel returned to Meridian Medical Technologies in 2001 as Vice President of Sales, and later became Senior Vice President of Commercial Pharmaceuticals until 2014. From 2006 to 2011, they also served as Senior Vice President of Commercial Pharmaceuticals at King Pharmaceuticals Canada.

In 2014, Handel became General Manager and President of Meridian Medical Technologies, Inc., a Pfizer Company. Tom stayed in this position until December 2021.

In 2022, Handel joined Meridian Medical Technologies as Chief Commercial Officer (CCO), and then moved to Kindeva Drug Delivery in 2023 as the Commercial Head for Injectables and Health Security.

Tom Handel attended Saint Louis University from 1983 to 1987, where they obtained a Bachelor of Science degree in Biology, General. Following this, from 1989 to 1991, they pursued a Master of Business Administration (MBA) at Maryville University of Saint Louis, specializing in Business/International Marketing.